Vaccine-induced immune thrombotic thrombocytopenia
In response to the COVID-19 pandemic, vaccines for SARS-CoV-2 were developed, tested,
and introduced at a remarkable speed. Although the vaccine introduction had a major …
and introduced at a remarkable speed. Although the vaccine introduction had a major …
Clinical characteristics and pharmacological management of COVID-19 vaccine–induced immune thrombotic thrombocytopenia with cerebral venous sinus …
Importance The COVID-19 pandemic saw one of the fastest developments of vaccines in an
effort to combat an out-of-control pandemic. The 2 most common COVID-19 vaccine …
effort to combat an out-of-control pandemic. The 2 most common COVID-19 vaccine …
COVID-19 and thrombosis: The role of hemodynamics
Abstract Severe coronavirus disease 2019 (COVID-19) is characterized by an increased risk
of thromboembolic events, a leading cause for adverse outcomes in patients afflicted by the …
of thromboembolic events, a leading cause for adverse outcomes in patients afflicted by the …
Antiplatelets and antithrombotics in neurointerventional procedures: Guideline update
CM Schirmer, KR Bulsara, F Al-Mufti… - Journal of …, 2023 - jnis.bmj.com
Background Antiplatelet and antithrombotic medication management before, during, and
after neurointerventional procedures has significant practice variation. This document …
after neurointerventional procedures has significant practice variation. This document …
Cerebral venous sinus thrombosis following COVID-19 vaccination: analysis of 552 worldwide cases
C de Gregorio, L Colarusso, G Calcaterra… - Vaccines, 2022 - mdpi.com
To date, billions of vaccine doses have been administered to restrain the current COVID-19
pandemic worldwide. Rare side effects, including intravascular blood clots, were reported in …
pandemic worldwide. Rare side effects, including intravascular blood clots, were reported in …
Endovascular treatment of intracranial vein and venous sinus thrombosis—a systematic review
P Buecke, V Hellstern, A Cimpoca, JE Cohen… - Journal of clinical …, 2022 - mdpi.com
Background: Cerebral venous sinus or vein thromboses (SVT) are treated with heparin
followed by oral anticoagulation. Even after receiving the best medical treatment, numerous …
followed by oral anticoagulation. Even after receiving the best medical treatment, numerous …
[HTML][HTML] Cerebral venous sinus thrombosis and thrombocytopenia due to heparin-independent anti-PF4 antibodies after adenovirus infection
G Uzun, J Zlamal, K Althaus, A Bevot… - …, 2024 - ncbi.nlm.nih.gov
Cerebral venous sinus thrombosis (CVST) is a rare cerebrovascular disorder predominantly
observed in adults, but can pose unique challenges in pediatric patients. 1 The underlying …
observed in adults, but can pose unique challenges in pediatric patients. 1 The underlying …
Fatal vaccine-induced immune thrombotic thrombocytopenia (VITT) post Ad26. COV2. S: First documented case outside US
Purpose We reported the first described post Ad26. COV2. S (Janssen, Johnson & Johnson)
vaccine-induced immune thrombocytopenia (VITT) case outside US. Case description CA …
vaccine-induced immune thrombocytopenia (VITT) case outside US. Case description CA …
Early versus late initiation of endovascular therapy in patients with severe cerebral venous sinus thrombosis
Background Endovascular therapy (EVT) for severe cerebral venous sinus thrombosis
(CVST) is controversial in terms of indication and clinical benefit. The impact of delay of EVT …
(CVST) is controversial in terms of indication and clinical benefit. The impact of delay of EVT …
Cerebral venous sinus thrombosis in traumatic brain injury: a systematic review of its complications, effect on mortality, diagnostic and therapeutic management, and …
DF Netteland, EC Sandset… - Frontiers in …, 2023 - frontiersin.org
Objective Cerebral venous sinus thrombosis (CVST) is increasingly being recognized in the
setting of traumatic brain injury (TBI), but its effect on TBI patients and its management …
setting of traumatic brain injury (TBI), but its effect on TBI patients and its management …